Sana's UP421 Stem Cell Transplant Shows Promise in Type 1 Diabetes

Sana’s UP421 Stem Cell Transplant Shows Promise in Type 1 Diabetes

Bydiabetesknow

Sana Biotechnology’s new type of stem cell transplant islet cells shows promise for a potential treatment for type 1 diabetes. The therapy, UP421 stem cell transplant enrolled patients to avoid immune rejection and produce insulin.

As Per-Ola Carlsson, M.D., study principal pnvestigator, senior physician and professor at the Clinic for Endocrinology and Diabetology at Uppsala University Hospital. “The clinical data are highly promising for patients and provide the first evidence in humans for overcoming allogeneic and autoimmune rejection with pancreatic islet cell transplantation in type 1 diabetes with no immunosuppression.”

Read the full UP421 stem cell transplant article here!

Share this post:

Share on Pinterest Share on LinkedIn Share on Reddit

You'll find articles on diabetes knowledge, nutrition, low-carb keto diet information, fitness and exercise programs to help keep diabetics in optimal diabetes health. Take advantage of our diabetic health tools for a healthier lifestyle!

Similar Posts

Diabetes Cured in Mice Using New Human Stem Cell Therapy

Diabetes Cured in Mice Using New Human Stem Cell Therapy

Bydiabetesknow

Diabetes Cured in Mice Using New Human Stem Cell Therapy Researchers from Washington University School of Medicine have cured mice of diabetes using a new human stem cell therapy. The technique converts human stem cells into insulin-producing cells. When the insulin secreting cells were infused into mice with severe diabetes, within two weeks their blood glucose…

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Bydiabetesknow

Previously Published on Genprex.com — Genprex, Inc. (“Genprex” or the “Company”) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that data highlighting the potential of Genprex’s gene therapy for Type 1 diabetes is being presented by its research collaborators at the University of Pittsburgh (Pitt) at the 16th International…

Beta Bionics granted FDA Breakthrough Device Designation for iLet Bionic Pancreas System
|

Beta Bionics granted FDA Breakthrough Device Designation for iLet Bionic Pancreas System

Bydiabetesknow

Today Beta Bionics was granted FDA breakthrough device designation for the iLet bionic pancreas system. The designation was granted in all configurations of the iLet (insulin-only, glucagon-only and bihormonal). The meaning of FDA breakthrough device designation is to provide patients and health care providers with timely access to medical devices by speeding up their development, assessment, and review….

Bionic Pancreas Critical Hurdle
|

Bionic Pancreas Critical Hurdle, iLet

Bydiabetesknow

Bionic Pancreas Critical Hurdle! Beta Bionics recently won $12 million in supplemental funding from the National Institutes of Health (NIH) to conduct a major multicenter, national clinical trials for the iLet™ (bionic pancreas). Developed by Edward Damiano (Beta Bionics) and Firas El-Khatib. They hope to have the device approved for market in about a year….

A Cure for Type 1 Diabetes? It Has Worked for One Man
|

A Cure for Type 1 Diabetes? It Has Worked for One Man

Bydiabetesknow

Previously Published on dnyuz.com – Brian Shelton’s life was ruled by Type 1 diabetes. Could it be a cure for Type 1 Diabetes? It Has Worked for One Man. When his blood sugar plummeted, he would lose consciousness without warning. He crashed his motorcycle into a wall. He passed out in a customer’s yard while delivering mail….

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.